PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Ocimum Biosolutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Ocimum Biosolutions CEO Honored as 2011 Young Global Leader - Ocimum Biosolutions announced that Anuradha Acharya, Founder & CEO, has been honored as a 2011 Young Global Leader by the World Economic Forum
Ocimum Biosolutions CEO Honored as 2011 Young Global Leader

 

NewswireToday - /newswire/ - Gaithersburg, MD, United States, 2011/03/10 - Ocimum Biosolutions announced that Anuradha Acharya, Founder & CEO, has been honored as a 2011 Young Global Leader by the World Economic Forum.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The honor, bestowed annually since its inception in 2004, acknowledges 100-200 excellent young leaders from across the globe for their professional achievements, commitment to society at large and prospective contribution to shaping the global future.

Anu Acharya is now a member of the Forum of Young Global Leaders that works in tandem with the World Economic Forum towards discovering innovative solutions to current global challenges while building the next-generation leadership community. She said, “I am honored and thrilled to be part of the Young Global Leaders community by the World Economic Forum. The YGL platform is a powerful peer group that will enable us to contribute more effectively to the future of the world. I am looking forward to being actively involved in YGL”.

This year, the World Economic Forum (weforum.org) has named 190 Young Global Leaders, out of which 18 are from South Asia and 12 from India.

About Anu Acharya

Ms. Anu Acharya is the Founder & CEO of Ocimum Biosolutions, a global genomics outsourcing partner for discovery, development and diagnostics. Since founding the company in 2000, she has piloted it to great heights through strategic international acquisitions, capital raises for equity investments and launch of innovative products, solutions and services. At Ocimum, she also mentors committees for resource development and Corporate Social Responsibility.

Prior to founding Ocimum Biosolutions, Ms. Acharya has had rich experience in the Telecom, IT and entrepreneurship arenas. She worked for a start-up in the telecommunications space called Mantiss Information and a consulting firm called SEI Information where she helped create a social networking site for entrepreneurs. Her experience is backed by education at premier institutions such as the Indian Institute of Technology at Kharagpur, India (IIT) and University of Illinois where she has two Post Graduate degrees in Physics and MIS.

She is a regular in technology forums and round tables and one of the well-known first generation entrepreneurs in the Indian life sciences space. She was selected by Red Herring Magazine to the list of “25 Tech Titans under 35″ in 2006. Ocimum has received several awards including “Fastest Growing Life Sciences Company in India”, Red Herring Asia 100, “IT Innovation Award” by NASSCOM and has been named to the Deloitte list of Fastest Growing companies in Asia, four years in a row. She has been named Biospectrum “Entrepreneur of the Year” for 2008 and also has been awarded the Astia Life Science Innovators Award in the same year. She is one of the 12 Young Global Leaders selected in 2011 from India.

About Ocimum Biosolutions

Ocimum Biosolutions (ocimumbio.com) is an leading integrated global genomics outsourcing partner with solutions spanning Bioresearch Design and Execution; Data Analytics and Insights; Laboratory, Sample & Data Management; and Integrated Solutions. Ocimum provides comprehensive genomic services and reference databases; data analysis; biorepository services such as sample accrual & collection, IRB approvals, CRO training, sample, clinical data capture and management; life science lab information management solutions; and also offers both research level and GLP-compliant services. Majority of the top 25 pharma & biotech companies and leading research institutes worldwide have chosen Ocimum as their preferred genomics outsourcing partner. Ocimum is one of three Indian companies that successfully developed an indigenous, relatively low-cost H1N1 Swine Flu H1N1 detection kit in 2010.

About The World Economic Forum
The World Economic Forum (weforum.org) is an independent international organization committed to improving the state of the world by engaging leaders in partnerships to shape global, regional and industry agendas.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Ocimum Biosolutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Ocimum Biosolutions CEO Honored as 2011 Young Global Leader

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: OcimumBio.com 
+91 40 66986700 row[.]ocimumbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Ocimum Biosolutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Ocimum Biosolutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)